Dr. James Eason, the surgeon who performed Steve Jobs' liver transplant earlier this year, came close to -- but did not actually confirm -- that Jobs' cancer had spread to his liver.
It was Dr. Eason who, with his patient's permission, issued a four-paragraph statement in June confirming reports that Apple's (AAPL) CEO had received a new liver. Eason, the head of transplantation at Methodist University Hospital in Memphis, also revealed MOREPhilip Elmer-DeWitt - Aug 21, 2009 10:09 AM ET
Friday's Wall Street Journal carries a report on the state of Steve Jobs' health that makes his condition last January -- before he went on a six month medical leave -- sound more desperate than Apple (AAPL) let on at the time.
"He was one real sick guy,'' an unnamed source told the Journal. "Fundamentally he was starving to death over a nine-month period. He couldn't digest protein. [But] he took MOREPhilip Elmer-DeWitt - Jun 4, 2009 9:18 PM ET
It takes him nine paragraphs to get to it, but there's a nugget of Apple (AAPL) news in Robert X. Cringely's latest column, "Where's Steve?," published Saturday.
Cringely, the pen name of former InfoWorld and PBS columnist Mark Stephens, sets it up with a quote from Oscar Wilde ("The only thing worse than being talked about is not being talked about.") and a leisurely discourse on how Steve Jobs, MOREPhilip Elmer-DeWitt - Feb 22, 2009 7:11 AM ET
On Christmas Eve, at the height of a holiday season that Steve Jobs claimed was the first in a decade he got to spend with his family, Apple's (AAPL) ailing CEO was on the phone screaming at the chairman of Sony Music (SNE).
That's the picture Tim Arango paints in Monday's New York Times in an article that describes the "tense and antagonistic" relations behind the seemingly harmonious music pricing agreement MOREPhilip Elmer-DeWitt - Feb 2, 2009 9:44 AM ET
The report Wednesday that the Securities and Exchange Commission is looking closely at Apple's disclosures about the state of Steve Jobs' health (link) follows speculation last week that stockholders are also likely to file lawsuits against the company.
The issue, of course, is whether Apple (AAPL) and Jobs misled investors by issuing first good news ("hormone imbalance") that drove the stock up, followed by bad news ("medical leave") that drove it MOREPhilip Elmer-DeWitt - Jan 21, 2009 11:16 AM ET
He was a Titan who stole fire from the gods and gave to mankind the tool that allowed mortals to rise above the beasts. For his sins, Jupiter had him chained to a rock on Mount Caucasus. Every day a vulture feasted on his liver, which grew back overnight.
Steve Jobs, who announced on Wednesday that he is taking a medical leave to focus on his health, must feel something MOREPhilip Elmer-DeWitt - Jan 18, 2009 5:25 AM ET
Getting the kind of information about Steve Jobs' health that Apple's (AAPL) investors and customers deserve is tricky, as tech reporters discovered to their peril this week.
The sources in the best position to talk about Jobs' medical condition -- which forced him to announce Wednesday that he taking a six-month medical leave -- are his physicians, and they're prevented by doctor-patient confidentiality from disclosing what they know.
Everybody else is MOREPhilip Elmer-DeWitt - Jan 15, 2009 11:25 AM ET
Apple (AAPL) shares dropped 7.56% to $78.88 in after-hours trading in New York on news Wednesday that COO Tim Cook was taking over day-to-day operations -- a $6.7 billion hit on Apple's market capitalization.
This is not the first time Cook has stepped in while Steve Jobs dealt with a serious medical condition.
Cook ran the shop for a month in 2004 while Jobs recovered from surgery that removed a malignant tumor MOREPhilip Elmer-DeWitt - Jan 15, 2009 8:05 AM ET
In his second public health update in as many weeks, Apple CEO Steve Jobs acknowledged Wednesday that his health problems are "more complex" than he thought and that he would be stepping down until the end of June to deal with them.
The news came in an e-mail sent to employees -- and released by Apple after the close of trading.
In the interim, chief operating officer Tim Cook will run the MOREPhilip Elmer-DeWitt - Jan 14, 2009 4:55 PM ET
Oppenheimer & Co.'s Yair Reiner turned heads on Wall Street three weeks ago -- in the wake of Apple's surprise announcement that Steve Jobs would be skipping Macworld 2009 -- when the analyst downgraded the company and refused to set a price target for its shares until he got some answers. (See Analyst sounds warning.)
On Tuesday, Reiner reinstated Apple (AAPL), upgrading the stock to "outperform" and setting a 12 - MOREPhilip Elmer-DeWitt - Jan 6, 2009 10:32 AM ET
|China to fight pollution with drones|
|The medical marijuana ad that never aired, despite contrary media headlines|
|2 million students missing out on college aid|
|Boeing reports wing cracks on Dreamliners|
|Bitcoin matters. Ignore the media circus.|